Cardiac thrombolysis is a medical intervention aimed at dissolving blood clots within the coronary arteries, which are vital vessels supplying the heart muscle with oxygen and nutrients. This procedure is commonly employed in the management of acute myocardial infarction, also known as a heart attack. During a heart attack, a blood clot can obstruct blood flow to a part of the heart, leading to tissue damage and potentially life-threatening complications. Cardiac thrombolysis involves the administration of thrombolytic agents, or clot-busting drugs, to break down the clot and restore blood flow to the affected area of the heart. This timely intervention is crucial in minimizing myocardial damage and improving the chances of a positive outcome. While cardiac thrombolysis has proven effective in certain cases, it is not suitable for all patients, and individual factors such as the time elapsed since the onset of symptoms and the patient's overall health must be carefully considered by healthcare professionals before deciding on this treatment approach.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation